✦ LIBER ✦

Phase II study of a gemcitabine and cisplatin combination regimen in taxane resistant metastatic breast cancer

✍ Scribed by Jae Hong Seo; Sang Cheul Oh; Cheul Won Choi; Byung Soo Kim; Sang Won Shin; Yeul Hong Kim; Jun Suk Kim; Ae-Ree Kim; Jae-Bok Lee; Bum Hwan Koo

Publisher: Springer
Year: 2006
Tongue: English
Weight: 265 KB
Volume: 59
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-006-0266-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I/II study of a combined gemcitabi

Phase I/II study of a combined gemcitabine, etoposide, and cisplatin chemotherapy regimen for metastatic urothelial carcinoma

✍ Tetsuro Tsukamoto; Junji Yonese; Yuhei Ohkubo; Iwao Fukui 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

## Abstract ## BACKGROUND The authors attempted to determine the maximum tolerated dose (MTD) of gemcitabine in combination with etoposide and cisplatin as a chemotherapy regimen and investigated the safety and antitumor activity with the recommended doses of gemcitabine with etoposide and cisplat

Gemcitabine as prolonged infusion and vi

Gemcitabine as prolonged infusion and vinorelbine in anthracycline and/or taxane pretreated metastatic breast cancer: a phase II study

✍ Peter Schmid; Volker Heilmann; Carsten-Oliver Schulz; Annette Dieing; Silvia Leh 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 205 KB

High efficacy of gemcitabine and cisplat

High efficacy of gemcitabine and cisplatin in patients with predominantly anthracycline- and taxane-pretreated metastatic breast cancer

✍ V. Heinemann; H. J. Stemmler; A. Wohlrab; D. Bosse; C. Losem; S. Kahlert; G. Rau 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 235 KB

Phase II study of docetaxel and cisplati

Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic gastric cancer

✍ Keon Woo Park; Jin Seok Ahn; Young Suk Park; Jeeyun Lee; Jung Hoon Kang; Joon Oh 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 223 KB

Cisplatin, epirubicin, and lonidamine co

Cisplatin, epirubicin, and lonidamine combination regimen as first-line chemotherapy for metastatic breast cancer: a pilot study

✍ L. Dogliotti; S. Danese; A. Berruti; P. Zola; T. Buniva; A. Bottini; G. Richiard 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 162 KB

A phase II study of biweekly pemetrexed

A phase II study of biweekly pemetrexed and gemcitabine in patients with metastatic breast cancer

✍ Susan F. Dent; Stan Gertler; Shailendra Verma; Roanne Segal; Vince Young; Rakesh 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 215 KB